iZafe Group AB (publ) (IZAFE-B.ST)
SEK 0.25
(-2.34%)
SEK 0.25
(-2.34%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 3.17 Million SEK | -20.61% |
| 2022 | 3.99 Million SEK | 266.88% |
| 2021 | 1.09 Million SEK | 45.33% |
| 2020 | 750 Thousand SEK | -93.14% |
| 2019 | 10.93 Million SEK | -4.71% |
| 2018 | 11.47 Million SEK | 1600.3% |
| 2017 | 675 Thousand SEK | -30.77% |
| 2016 | 975 Thousand SEK | -23.53% |
| 2015 | 1.27 Million SEK | -33.73% |
| 2014 | 1.92 Million SEK | 38.64% |
| 2013 | 1.38 Million SEK | 197.69% |
| 2012 | 466.15 Thousand SEK | 74.36% |
| 2011 | 267.35 Thousand SEK | -60.49% |
| 2010 | 676.73 Thousand SEK | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 2.63 Million SEK | -16.88% |
| 2024 Q2 | 2.5 Million SEK | -5.04% |
| 2024 Q3 | 6.95 Million SEK | 188.11% |
| 2023 Q2 | 3.02 Million SEK | -18.09% |
| 2023 Q4 | 3.17 Million SEK | 14.29% |
| 2023 Q3 | 2.77 Million SEK | -8.29% |
| 2023 FY | 3.17 Million SEK | -20.61% |
| 2023 Q1 | 3.69 Million SEK | -7.53% |
| 2022 Q3 | 1.04 Million SEK | -74.26% |
| 2022 FY | 3.99 Million SEK | 266.88% |
| 2022 Q1 | 4.71 Million SEK | 332.66% |
| 2022 Q2 | 4.05 Million SEK | -14.08% |
| 2022 Q4 | 3.99 Million SEK | 283.41% |
| 2021 Q1 | 15.58 Million SEK | 1978.0% |
| 2021 FY | 1.09 Million SEK | 45.33% |
| 2021 Q4 | 1.09 Million SEK | -94.34% |
| 2021 Q3 | 19.24 Million SEK | -1.33% |
| 2021 Q2 | 19.5 Million SEK | 25.17% |
| 2020 Q4 | 750 Thousand SEK | -9.09% |
| 2020 Q1 | 7.61 Million SEK | -30.41% |
| 2020 Q2 | 9.9 Million SEK | 30.07% |
| 2020 Q3 | 825 Thousand SEK | -91.67% |
| 2020 FY | 750 Thousand SEK | -93.14% |
| 2019 Q3 | 8.04 Million SEK | -18.31% |
| 2019 FY | 10.93 Million SEK | -4.71% |
| 2019 Q4 | 10.93 Million SEK | 35.93% |
| 2019 Q1 | 5.32 Million SEK | -53.59% |
| 2019 Q2 | 9.85 Million SEK | 84.91% |
| 2018 Q4 | 11.47 Million SEK | 33.91% |
| 2018 FY | 11.47 Million SEK | 1600.3% |
| 2018 Q2 | 3.25 Million SEK | 420.0% |
| 2018 Q3 | 8.57 Million SEK | 163.72% |
| 2018 Q1 | 625 Thousand SEK | -7.41% |
| 2017 FY | 675 Thousand SEK | -30.77% |
| 2017 Q1 | 900 Thousand SEK | -7.69% |
| 2017 Q2 | 825 Thousand SEK | -8.33% |
| 2017 Q3 | 775 Thousand SEK | -6.06% |
| 2017 Q4 | 675 Thousand SEK | -12.9% |
| 2016 Q2 | 1.09 Million SEK | 0.0% |
| 2016 Q4 | 975 Thousand SEK | 0.0% |
| 2016 FY | 975 Thousand SEK | -23.53% |
| 2016 Q1 | - SEK | -100.0% |
| 2015 Q1 | 1.45 Million SEK | -24.41% |
| 2015 FY | 1.27 Million SEK | -33.73% |
| 2015 Q4 | 1.27 Million SEK | 0.0% |
| 2015 Q3 | 1.27 Million SEK | -12.32% |
| 2015 Q2 | 1.45 Million SEK | 0.0% |
| 2014 Q3 | 1.92 Million SEK | 6.13% |
| 2014 Q1 | 1.35 Million SEK | -2.44% |
| 2014 Q2 | 1.81 Million SEK | 33.9% |
| 2014 FY | 1.92 Million SEK | 38.64% |
| 2014 Q4 | 1.92 Million SEK | 0.0% |
| 2013 Q1 | 746.9 Thousand SEK | 60.23% |
| 2013 Q4 | 1.38 Million SEK | 13.55% |
| 2013 Q3 | 1.22 Million SEK | 21.66% |
| 2013 Q2 | 1 Million SEK | 34.5% |
| 2013 FY | 1.38 Million SEK | 197.69% |
| 2012 FY | 466.15 Thousand SEK | 74.36% |
| 2012 Q3 | - SEK | 0.0% |
| 2012 Q4 | 466.15 Thousand SEK | 0.0% |
| 2011 FY | 267.35 Thousand SEK | -60.49% |
| 2010 FY | 676.73 Thousand SEK | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| AddLife AB (publ) | 5.28 Billion SEK | 99.94% |
| Biotage AB (publ) | 150 Million SEK | 97.883% |
| Bonesupport Holding AB (publ) | 17.48 Million SEK | 81.841% |
| Doxa AB (publ) | 9.7 Million SEK | 67.268% |
| Elekta AB (publ) | 7.24 Billion SEK | 99.956% |
| Ortivus AB (publ) | 5.48 Million SEK | 42.073% |
| Ortivus AB (publ) | 5.48 Million SEK | 42.073% |
| Q-linea AB (publ) | 20.56 Million SEK | 84.561% |
| S2Medical AB (publ) | - SEK | -Infinity% |
| Synsam AB (publ) | 3.25 Billion SEK | 99.902% |